Инфицированность вирусом папилломы человека при патологиях полового члена (систематический обзор литературы)
pdf

Ключевые слова

ВПЧ
рак полового члена
ВПЧ высокого канцерогенного риска
вакцинация при ВПЧ

Как цитировать

Гаптулбарова, К. А., Ибрагимова , М. К., & Литвяков, Н. В. (2023). Инфицированность вирусом папилломы человека при патологиях полового члена (систематический обзор литературы). Вопросы онкологии, 69(5), 815–823. https://doi.org/10.37469/0507-3758-2023-69-5-815-823

Аннотация

Введение. Этиология рака полового члена (РПЧ) является многофакторной, в частности, интересным вопросом является ассоциация инфицирования вирусом папилломы человека (ВПЧ) с риском развития рака полового члена. Имеющиеся в литературе результаты по выявлению ВПЧ при новообразованиях полового члена очень противоречивы по сравнению с аналогичными при других ВПЧ-ассоциированных онкопатологиях.

Цель исследования. Систематизация имеющихся мировых литературных данных относительно связи наличия ВПЧ-инфекции с риском возникновения рака полового члена.

Материалы и методы. Поиск проводился с помощью баз данных Pubmed, NCBI и поискового сервиса Google scholar. В результате литературного поиска первично было получено 205 статей по изучаемой тематике, опубликованных с 1991 по 2020 гг. В окончательный анализ вошли 9 исследований, соответствующие абсолютно всем заданным параметрам.

Результаты. Показано, что ВПЧ определяется почти в равной степени как при доброкачественных образованиях и предраковых поражениях полового члена, так и среди образцов нормальной ткани полового члена (контрольных групп). В то время как имеется значительное отличие в количестве ВПЧ-положительных пациентов среди больных с диагнозом рак полового члена и контрольной группой, OR = 142,6. Также определено, что самыми распространёнными генотипами ВПЧ высокого канцерогенного риска (ВКР) оказались 16 и 18.

Заключение. Результаты систематического обзора подтвердили высокую степень риска возникновения РПЧ при наличии ВПЧ инфекции, а также высокий уровень инфицированности ВПЧ при РПЧ (62,0 %).

https://doi.org/10.37469/0507-3758-2023-69-5-815-823
pdf

Библиографические ссылки

Kidd LC. Chaing S, Chipolliniet J, et al. Relationship between human papillomavirus and penile cancer—implications for prevention and treatment. Translational andrology and urology. 2017;6(5):791. https://doi.org/10.21037/tau.2017.06.27.

Kombe Kombe AJ, Li B, Zahid A, et al. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Frontiers in Public Health. 2021;8:1003. https://doi.org/10.3389/fpubh.2020.552028.

Pow-Sang MR, Ferreira U, Pow-Sang JM, et al. Epidemiology and natural history of penile cancer. Urology. 2010;76(2):S2-S6. https://doi.org/10.1016/j.urology.2010.03.003.

Аксель ЕМ, Матвеев ВБ. Статистика злокачественных новообразований мочевых и мужских половых органов в России и странах бывшего СССР. Онкоурология. 2019;15(2):15-24 [Axel EM, Matveev VВ. Statistics of malignant tumors of urinary and male urogenital organs in Russia and the countries of the former USSR. Cancer Urology. 2019;15(2):15-24 (In Russ.)]. https://doi.org/10.17650/1726-9776-2019-15-2-15-24.

Брико НИ, Лопухов ПД, Каприн АД, и др. ВПЧ-ассоциированные поражения в Российской Федерации: оценка состояния проблемы. Современная онкология. 2019;21(1):45-50 [Briko NI, Lopukhov PD, Kaprin AD, et al. HPV-associated lesions in the Russian Federation: assessment of the problem. Journal of Modern Oncology. 2019;21(1):45-50 (In Russ.)]. https://doi.org/10.26442/18151434.2019.190199.

Schlenker B, Schneede P. The role of human papilloma virus in penile cancer prevention and new therapeutic agents. European Urology Focus. 2019;5(1):42-5. http://dx.doi.org/10.1016/j.euf.2018.09.010

Brouwer OR, Albersen M, Parnham A, et al. European Association of Urology-American Society of Clinical Oncology collaborative guideline on penile cancer: 2023 update. European Urology. 2023;83(6):548-60. http://dx.doi.org/10.1016/j.eururo.2023.02.027.

Moch H, Amin MB, Berney DM, et al. The 2022 World Health Organization classification of tumours of the urinary system and male genital organs—part a: renal, penile, and testicular tumours. European Urology. 2022;82(5):458-68. http://dx.doi.org/10.1016/j.eururo.2022.06.016.

Brouwer OR, Albersen M, Parnham A, et al. European Association of Urology-American Society of Clinical Oncology collaborative guideline on penile cancer: 2023 update, Eur Urol. 2023;83(Issue6):548-560. https://doi.org/10.1016/j.eururo.2023.02.027.

Lu B, Wu Y, Nielson CM, et al. Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of us men: a prospective study. The Journal of Infectious Diseases. 2009;199(3):362-71. http://dx.doi.org/10.1086/596050.

Giuliano AR, Lee J-H, Fulp W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. The Lancet. 2011;377(9769):932-40. http://dx.doi.org/10.1016/s0140-6736(10)62342-2.

Kayes O, Ahmed HU, Arya M, et al. Molecular and genetic pathways in penile cancer. The Lancet Oncology. 2007;8(5):420-9. http://dx.doi.org/10.1016/s1470-2045(07)70137-7.

Backes DM, Kurman RJ, Pimenta JM, et al. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes & Control. 2008;20(4):449-57. http://dx.doi.org/10.1007/s10552-008-9276-9.

Dai B, Ye D-W, Zhu Y-P, et al. Relationship between circumcision and human papillomavirus infection: a systematic review and meta-analysis. Asian Journal of Andrology. 2017;19(1):125. http://dx.doi.org/10.4103/1008-682x.175092.

Iorga L, Marcu R, Diaconu C, et al. Penile carcinoma and HPV infection (Review). Experimental and Therapeutic Medicine. 2020;20(1):91-96. http://dx.doi.org/10.3892/etm.2019.8181.

Wolbarst AbrL. Circumcision And Penile Cancer. The Lancet. 1932;219(5655):150-3. http://dx.doi.org/10.1016/s0140-6736(01)24346-3.

Hebnes JB, Munk C, Frederiksen K, et al. The role of circumcision, tobacco, and alcohol use in genital human papillomavirus infection among men from Denmark. Int J STD AIDS. 2021;32(11):1028-1035. https://doi.org/10.1177/09564624211014727.

Saibishkumar EP, Crook J, Sweet J. Neonatal circumcision and invasive squamous cell carcinoma of the penis: a report of 3 cases and a review of the literature. Canadian Urological Association Journal. 2013;2(1):39. http://dx.doi.org/10.5489/cuaj.525.

Harder T, Wichmann O, Klug SJ, et al. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review. BMC Medicine. 2018;16(1). http://dx.doi.org/10.1186/s12916-018-1098-3.

Giuliano AR, Viscidi R, Torres BN, et al. Seroconversion following anal and genital HPV infection in men: The HIM study. Papillomavirus Research. 2015;1:109-15. http://dx.doi.org/10.1016/j.pvr.2015.06.007.

Hillman RJ, Giuliano AR, Palefsky JM, et al. Immunogenicity of the quadrivalent human papillomavirus (Type 6/11/16/18) vaccine in males 16 to 26 years old. Clinical and Vaccine Immunology. 2012;19(2):261-7. http://dx.doi.org/10.1128/cvi.05208-11.

Glombik D, Oxelbark Å, Sundqvist P, et al. Risk of second HPV-associated cancers in men with penile cancer. Acta Oncologica. 2021;60(5):667-71. http://dx.doi.org/10.1080/0284186x.2021.1885056.

Araújo LA de, De Paula AAP, de Paula H da SC, et al. Human papillomavirus (HPV) genotype distribution in penile carcinoma: Association with clinic pathological factors. Tornesello ML, editor. PloS one. 2018;13(6):e0199557. http://dx.doi.org/10.1371/journal.pone.0199557.

Gu W, Zhang P, Zhang G, et al. Importance of HPV in chinese penile cancer: a contemporary multicenter study. Frontiers in Oncology. 2020;10. http://dx.doi.org/10.3389/fonc.2020.01521.

Varma VA, Sanchez-Lanier M, Unger ER, et al. Association of human papillomavirus with penile carcinoma: A study using polymerase chain reaction and in situ hybridization. Human Pathology. 1991;22(9):908-13. http://dx.doi.org/10.1016/0046-8177(91)90181-n.

Iwasawa A, Kumamoto Y, Fujinaga K. Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization. Journal of Urology. 1993;149(1):59-63. http://dx.doi.org/10.1016/s0022-5347(17)35999-2.

Suzuki H, Sato N, Kodama T, et al. Detection of human papillomavirus DNA and state of p53 gene in Japanese penile cancer. Jpn J Clin Oncol. 1994;24(1):1-6.

Gregoire L, Cubilla AL, Reuter VE, et al. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst. 1995;87(22):1705-9. http://dx.doi.org/10.1093/jnci/87.22.17.05.

Bezerra AL, Lopes A, Santiago GH, et al. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer. 2001;91(12):2315-21.

Humbey O, Cairey-Remonnay S, Guérrini JS, et al. Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas. European Journal of Cancer. 2003;39(5):684-90. http://dx.doi.org/10.1016/s0959-8049(02)00835-3.

Lont AP, Kroon BK, Horenblas S, et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer. 2006;119(5):1078-81. http://dx.doi.org/10.1002/ijc.21961.

Senba M, Kumatori A, Fujita S, et al. The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand. Journal of Medical Virology. 2006;78(10):1341-6. http://dx.doi.org/10.1002/jmv.20703.

Prowse DM, Ktori EN, Chandrasekaran D, et al. Human papillomavirus-associated increase in p16INK4A expression in penile lichen sclerosus and squamous cell carcinoma. British Journal of Dermatology. 2007;158(2):261-5. http://dx.doi.org/10.1111/j.1365-2133.2007.08305.x.

Scheiner MA, Campos MM, Ornellas AA, et al. Human papillomavirus and penile cancers in Rio de Janeiro, Brazil: HPV typing and clinical features. International braz j urol. 2008;34(4):467-76. http://dx.doi.org/10.1590/s1677-55382008000400009.

Guerrero D, Guarch R, Ojer A, et al. Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma. BJU International [Internet]. 2008;102(6):747-55. http://dx.doi.org/10.1111/j.1464-410x.2008.07603.x.

Yanagawa N, Osakabe M, Hayashi M, et al. Detection of HPV-DNA,p53alterations, and methylation in penile squamous cell carcinoma in Japanese men. Pathol Int. 2008;58(8):477-82. http://dx.doi.org/10.1111/j.1440-1827.2008.02259.x.

Tornesello ML, Duraturo ML, Losito S, et al. Human papillomavirus genotypes and HPV16 variants in penile carcinoma. International Journal of Cancer. 2007;122(1):132-7. http://dx.doi.org/10.1002/ijc.23062.

Krustrup D, Jensen HL, van den Brule AJC, et al. Histological characteristics of human papilloma-virus-positive and -negative invasive andin situsquamous cell tumours of the penis. International J Exp Pathol. 2009;90(2):182-9. http://dx.doi.org/10.1111/j.1365-2613.2008.00636.x.

Cubilla AL, Lloveras B, Alejo M, et al. The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from paraguay. Am J Surg Pathol. 2010;34(1):104-14. http://dx.doi.org/10.1097/pas.0b013e3181c76a49.

D’Hauwers KWM, Depuydt CE, Bogers JJ, et al. Human papillomavirus, lichen sclerosus and penile cancer: A study in Belgium. Vaccine. 2012;30(46):6573-7. http://dx.doi.org/10.1016/j.vaccine.2012.08.034.

Cubilla AL, Lloveras B, Alemany L, et al. Basaloid squamous cell carcinoma of the penis with papillary features. Am J Surg Pathol. 2012;36(6):869-75. http://dx.doi.org/10.1097/pas.0b013e318249c6f3

Do HTT, Koriyama C, Khan NA, et al. The etiologic role of human papillomavirus in penile cancers: a study in Vietnam. British Journal of Cancer. 2013;108(1):229-33. http://dx.doi.org/10.1038/bjc.2012.583.

Hernandez BY, Goodman MT, Unger ER, et al. Human Papillomavirus Genotype Prevalence in Invasive Penile Cancers from a Registry-Based United States Population. Frontiers in Oncology. 2014;4. http://dx.doi.org/10.3389/fonc.2014.00009.

Lebelo RL, Boulet G, Nkosi CM, et al. Diversity of HPV types in cancerous and pre-cancerous penile lesions of South African men: Implications for future HPV vaccination strategies. Journal of Medical Virology. 2013;86(2):257-65. http://dx.doi.org/10.1002/jmv.23730.

Steinestel J, Al Ghazal A, Arndt A, et al. The role of histologic subtype, p16INK4a expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma. BMC Cancer. 2015;15(1). http://dx.doi.org/10.1186/s12885-015-1268-z.

Djajadiningrat RS, Jordanova ES, Kroon BK, et al. Human papillomavirus prevalence in invasive penile cancer and association with clinical outcome. Journal of Urology. 2015;193(2):526-31. http://dx.doi.org/10.1016/j.juro.2014.08.087.

Singh P, Sharma P, Panaiyadiyan S, et al. Association of human papillomavirus in penile cancer: A single-center analysis. Indian Journal of Urology. 2022;38(3):210. http://dx.doi.org/10.4103/iju.iju_41_22

Miralles-Guri C, Bruni L, Cubilla AL, et al. Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol. 2009;62(10):870-8. http://dx.doi.org/10.1136/jcp.2008.063149.

Fai EK, Bhutta HA, Ali K. Progression of a Buschke-Lowenstein tumor into invasive squamous cell carcinoma. JAAPA. 2019 Jun;32(6):1-4. http://dx.doi.org/10.1097/01.JAA.0000554740.24182.ae.

Haycox CL, Kuypers J, Krieger JN. Role of human papillomavirus typing in diagnosis and clinical decision making for a giant verrucous genital lesion. Urology. 1999;53(3):627-30. http://dx.doi.org/10.1016/s0090-4295(98)00351-3.

Sherman RN, Fung HK, Flynn KJ. Verrucous carcinoma (Buschke-Lowenstein tumor). Int J Dermatol. 1991;30(10):730-3. http://dx.doi.org/10.1111/j.1365-4362.1991.tb02622.x.

Pilotti S, Donghi R, D'Amato L, et al. HPV detection and p53 alteration in squamous cell verrucous malignancies of the lower genital tract. Diagn Mol Pathol. 1993;2(4):248-56.

Castrén K, Vähäkangas K, Heikkinen E, et al. Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein. Int J Cancer. 1998;77(5):674-8. http://dx.doi.org/10.1002/(sici)1097-0215(19980831)77:5<674::aid-ijc2>3.0.co;2-s.

Sasidharanpillai S, Ravishankar N, Kamath V, et al. Prevalence of human papillomavirus (HPV) DNA among men with oropharyngeal and anogenital cancers: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2021;22(5):1351-64. http://dx.doi.org/10.31557/apjcp.2021.22.5.1351.

Pan LJ, Ma JH, Zhang FL, et al. [HPV infection of the external genitalia in men whose female partners have cervical HPV infection (Chinese)]. Zhonghua Nan Ke Xue. 2018;24(6):516-519.

Beder Ribeiro CM, Ferrer I, Santos de Farias AB, et al. Oral and genital HPV genotypic concordance between sexual partners. Clinical Oral Investigations. 2013;18(1):261-8. http://dx.doi.org/10.1007/s00784-013-0959-6.

Hellberg D, Valentin J, Eklund T, et al. Penile cancer: is there an epidemiological role for smoking and sexual behaviour? BMJ. 1987;295(6609):1306-8. http://dx.doi.org/10.1136/bmj.295.6609.1306.

Maden C, Sherman KJ, Beckmann AM, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. JNCI Journal of the National Cancer Institute. 1993;85(1):19-24. http://dx.doi.org/10.1093/jnci/85.1.19.

Лицензия Creative Commons

Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.

© АННМО «Вопросы онкологии», Copyright (c) 2023